Although haploinsufficiency of Dyrk1A also causes severe neurological symptoms and developmental delay (15, 16, 17), these pharmacological inhibitors, when dosed well, appear to rescue Dyrk1A hyperactivity phenotypes only down to the WT level. Here, DYRK1A is linked to Global developmental delay.